204 related articles for article (PubMed ID: 34032899)
1. Comparison of the clinical course of COVID-19 infection in sickle cell disease patients with healthcare professionals.
Boğa C; Asma S; Leblebisatan G; Şen N; Tombak A; Demiroğlu YZ; Yeral M; Akın Ş; Yeşilağaç H; Habeşoğlu MA; Arıboğan A; Kasar M; Korur A; Özdoğu H
Ann Hematol; 2021 Sep; 100(9):2195-2202. PubMed ID: 34032899
[TBL] [Abstract][Full Text] [Related]
2. Long-term clinical outcomes and healthcare utilization of sickle cell disease patients with COVID-19: A 2.5-year follow-up study.
Feit A; Gordon M; Alamuri TT; Hou W; Mitchell WB; Manwani D; Duong TQ
Eur J Haematol; 2023 Oct; 111(4):636-643. PubMed ID: 37492929
[TBL] [Abstract][Full Text] [Related]
3. Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.
Minniti CP; Zaidi AU; Nouraie M; Manwani D; Crouch GD; Crouch AS; Callaghan MU; Carpenter S; Jacobs C; Han J; Simon J; Glassberg J; Gordeuk VR; Klings ES
Blood Adv; 2021 Jan; 5(1):207-215. PubMed ID: 33570644
[TBL] [Abstract][Full Text] [Related]
4. Severe COVID-19 with acute respiratory distress syndrome (ARDS) in a sickle cell disease adult patient: case report.
Teulier M; Elabbadi A; Gerotziafas G; Lionnet F; Voiriot G; Fartoukh M
BMC Pulm Med; 2021 Jan; 21(1):46. PubMed ID: 33514354
[TBL] [Abstract][Full Text] [Related]
5. Organ damage mitigation with the Baskent Sickle Cell Medical Care Development Program (BASCARE).
Ozdogu H; Boga C; Asma S; Kozanoglu I; Gereklioglu C; Yeral M; Buyukkurt NT; Solmaz S; Korur A; Aytan P; Maytalman E; Kasar M
Medicine (Baltimore); 2018 Feb; 97(6):e9844. PubMed ID: 29419693
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and sickle cell disease in Bahrain.
AbdulRahman A; AlAli S; Yaghi O; Shabaan M; Otoom S; Atkin SL; AlQahtani M
Int J Infect Dis; 2020 Dec; 101():14-16. PubMed ID: 32980556
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors associated with COVID-19 related severity in sickle cell disease.
Yurtsever N; Nandi V; Ziemba Y; Shi PA
Blood Cells Mol Dis; 2021 Dec; 92():102627. PubMed ID: 34823201
[TBL] [Abstract][Full Text] [Related]
8. Description of a national, multi-center registry of patients with sickle cell disease and SARS-CoV-2 infection: Data from the Pediatric COVID-19 United States Registry.
Dain AS; Diorio C; Fisher BT; Hankins JS; Witmer CM; Boustany M; Burton M; Ferrolino J; Sadaf S; Ross HS; Maron G;
Pediatr Blood Cancer; 2024 Jun; 71(6):e30909. PubMed ID: 38469996
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 infection among indian sickle cell disease patients.
Khargekar N; Shinde N; Banerjee A; Madkaikar M; Nadkarni A
Indian J Public Health; 2023; 67(1):112-116. PubMed ID: 37039215
[TBL] [Abstract][Full Text] [Related]
10. Sickle cell disease and coronavirus disease-2019 (COVID-19) infection: a single-center experience.
Devarashetty SP; Grewal US; Le Blanc K; Walton J; Jones T; Shi R; Master SR; Mansour RP; Ramadas P
Postgrad Med J; 2023 Aug; 99(1175):1008-1012. PubMed ID: 37399057
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Presentation in Patients with Sickle Cell Disease: A Case Series.
Chen-Goodspeed A; Idowu M
Am J Case Rep; 2021 May; 22():e931758. PubMed ID: 33941758
[TBL] [Abstract][Full Text] [Related]
12. COVID- 19 and sickle cell disease: autopsy findings of three deaths at the 37 Military Hospital, Accra, Ghana.
Attoh SA; Sarkodie E; Fatchu R; Kuma AB; Asumanu E; McAddy M; Toppar A; Hobenu F; Agyeman-Bediako K; Edusei L; Akakpo PK
Pan Afr Med J; 2022; 41():332. PubMed ID: 35865842
[TBL] [Abstract][Full Text] [Related]
13. Risk and protective factors for severe COVID-19 infection in a cohort of patients with sickle cell disease.
Cai J; Chen-Goodspeed A; Idowu M
J Investig Med; 2022 Jun; 70(5):1243-1246. PubMed ID: 35260481
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of COVID-19 hospitalizations in patients with sickle cell disease: A nationwide analysis.
Ilerhunmwuwa NP; Inyang L; Hakobyan N; Wasifuddin M; Tahir M; Aiwuyo H; Ankah P; Torere BE; Amaechi UM; Wang JC
Eur J Haematol; 2023 Sep; 111(3):432-440. PubMed ID: 37290934
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 and Sickle Cell Disease-Related Deaths Reported in the United States.
Payne AB; Schieve LA; Abe K; Hulihan M; Hooper WC; Hsu LL
Public Health Rep; 2022; 137(2):234-238. PubMed ID: 35060794
[TBL] [Abstract][Full Text] [Related]
16. The evolution of the COVID-19 pandemic in paediatric patients with sickle cell disease: From Alpha to Omicron.
Martin OY; Margulies S; Speller-Brown B; Majumdar S; Darbari DS; Campbell AD
Br J Haematol; 2023 Aug; 202(3):479-484. PubMed ID: 37217303
[TBL] [Abstract][Full Text] [Related]
17. Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020.
Panepinto JA; Brandow A; Mucalo L; Yusuf F; Singh A; Taylor B; Woods K; Payne AB; Peacock G; Schieve LA
Emerg Infect Dis; 2020 Oct; 26(10):2473-2476. PubMed ID: 32639228
[TBL] [Abstract][Full Text] [Related]
18. Anxiety level and clinical course of patients with sickle cell disease during the COVID-19 outbreak.
Tezol O; Unal S
Arch Pediatr; 2021 Feb; 28(2):136-140. PubMed ID: 33446428
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and venous thromboembolism risk in patients with sickle cell disease.
Singh A; Brandow AM; Wun T; Shet AS
Blood Adv; 2022 Aug; 6(15):4408-4412. PubMed ID: 35763429
[TBL] [Abstract][Full Text] [Related]
20. Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
Balanchivadze N; Kudirka AA; Askar S; Almadhoun K; Kuriakose P; Fadel R; Dabak V
Hemoglobin; 2020 Jul; 44(4):284-289. PubMed ID: 32722950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
